Our management’s extensive industry experience can accelerate your small molecule R&D and GMP program
Paul Lefebvre has worked in separations and purification for over 25 years. His experience with purification has been as both a vendor and a customer. He joined Averica in 2008 as the company’s first hire. He has worked to grow Averica into a full service chromatography CRO including purification by SFC and HPLC. In November 2018 Paul Lefebvre became General Manager of Averica Discovery Services. Prior to Averica, Paul worked at Waters Corporation developing and advancing mass-directed purification.
Dr. Berger brings over 20 years of experience working in analytical contract research and instrumentation companies. Prior to joining Averica Discovery, Dr. Berger served as Project Manager at PCI Synthesis, a contract manufacturing organization (CMO), where she managed million dollar projects developing drug substances. Previously, she served as Vice President and Co-Founder of Pion, Inc., an instrumentation company and CRO, where she oversaw instrumentation sales, the CRO laboratory, and project management. In addition to her responsibilities, Dr. Berger was a key contributor to the development of Pion’s instruments and intellectual property. She also established new markets for the company, expanding their service offerings. Dr. Berger earned her Ph.D. in Chemistry from Penn State University.
Kyle Kimmel is the Business Development Representative for Averica. He graduated from The University of California, Irvine, with a degree in Chemistry and then earned his Ph.D. in Organic Chemistry from University of California, Berkeley, while completing the last two years of doctorate study at Yale University. Since then, Kyle has worked as a Scientist for Dart Neuroscience, where he was the lead chemist and project manager for an early phase development program. He then became Senior Manager of Product Development at Intercept Pharmaceuticals. In this position, he acted as chemistry SME and provided technical oversight on all aspects of API chemistry projects, including synthesis, chemical development and manufacture. Now, Kyle leads business development activities at Averica, using his chemistry background to develop professional relationships with pharmaceutical companies and recommend the most suitable analytical and purification services for each client.
Dr. Powers joined our team in September 2019. He provides scientific leadership and manages the analytical laboratory. Over the past eight years, Wayne has worked in analytical development in various positions of increasing responsibility. He worked extensively developing and validating methods for HPLC, UPLC, and GC, as well as other analytical chemistry techniques. Dr. Powers received his Ph.D. in Chemistry from Rensselaer Polytechnic Institute.